These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 28599259)

  • 1. Predictive value of cystatin C in people with suspected or established coronary artery disease: A meta-analysis.
    Yang S; Song L; Zhao L; Dong P; Lai L; Wang H
    Atherosclerosis; 2017 Aug; 263():60-67. PubMed ID: 28599259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of circulating cystatin C level in patients with acute coronary syndrome: a meta-analysis.
    Jin S; Xu J; Shen G; Gu P
    Scand J Clin Lab Invest; 2021 Feb; 81(1):1-7. PubMed ID: 33207943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystatin C is independently associated with total and cardiovascular mortality in individuals undergoing coronary angiography. The Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
    Woitas RP; Kleber ME; Meinitzer A; Grammer TB; Silbernagel G; Pilz S; Tomaschitz A; Weihrauch G; Dobnig H; März W; Scharnagl H
    Atherosclerosis; 2013 Aug; 229(2):541-8. PubMed ID: 23706287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The predictive value of s-cystatin C for mortality after coronary artery bypass surgery.
    Dardashti A; Nozohoor S; Algotsson L; Ederoth P; Bjursten H
    J Thorac Cardiovasc Surg; 2016 Jul; 152(1):139-46. PubMed ID: 27056756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cystatin C levels on angiographic atherosclerosis progression and events among postmenopausal women with angiographically decompensated coronary artery disease (from the Women's Angiographic Vitamin and Estrogen [WAVE] study).
    Patel D; Ahmad S; Silverman A; Lindsay J
    Am J Cardiol; 2013 Jun; 111(12):1681-7. PubMed ID: 23499273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystatin C for predicting all-cause mortality and rehospitalization in patients with heart failure: a meta-analysis.
    Chen S; Tang Y; Zhou X
    Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30643006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased cystatin C levels as a risk factor of cardiovascular events in patients with preserved estimated glomerular filtration rate after elective percutaneous coronary intervention with drug-eluting stents.
    Sai E; Shimada K; Miyauchi K; Masaki Y; Kojima T; Miyazaki T; Kurata T; Ogita M; Tsuboi S; Yoshihara T; Miyazaki T; Ohsaka A; Daida H
    Heart Vessels; 2016 May; 31(5):694-701. PubMed ID: 25863806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated serum uric acid and risk of cardiovascular or all-cause mortality in people with suspected or definite coronary artery disease: A meta-analysis.
    Wang R; Song Y; Yan Y; Ding Z
    Atherosclerosis; 2016 Nov; 254():193-199. PubMed ID: 27755985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating levels of β2-microglobulin and cystatin C are associated with left atrial size: additional link between the kidney and the heart.
    Liu YS; Wang X; Jiang WD; Huang ZW; Wang YM; Hao L; Xing JL; Wang L; Liu XX; Lounsbury P; Zhang M; Lu QH
    Clin Nephrol; 2013 Sep; 80(3):168-76. PubMed ID: 23849305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystatin C and risk of mortality among patients undergoing percutaneous coronary intervention.
    Angeli F; Verdecchia P; Savonitto S; Arraiz G; Zaninotto M; Broccatelli A; Cosma C; De Servi S; Sabino F; Briguori C; Ambrosio G; Cavallini C;
    EuroIntervention; 2015 Nov; 11(7):757-64. PubMed ID: 25136879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of cystatin C in patients with acute coronary syndrome: A systematic review and meta-analysis.
    Sun Y; Lu Q; Cheng B; Tao X
    Eur J Clin Invest; 2021 Mar; 51(3):e13440. PubMed ID: 33128232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene study.
    Keller T; Messow CM; Lubos E; Nicaud V; Wild PS; Rupprecht HJ; Bickel C; Tzikas S; Peetz D; Lackner KJ; Tiret L; Münzel TF; Blankenberg S; Schnabel RB
    Eur Heart J; 2009 Feb; 30(3):314-20. PubMed ID: 19153178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystatin C and asymptomatic coronary artery disease in patients with metabolic syndrome and normal glomerular filtration rate.
    Qing X; Furong W; Yunxia L; Jian Z; Xuping W; Ling G
    Cardiovasc Diabetol; 2012 Sep; 11():108. PubMed ID: 22978689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney dysfunction and fatal cardiovascular disease--an association independent of atherosclerotic events: results from the Health, Aging, and Body Composition (Health ABC) study.
    Deo R; Fyr CL; Fried LF; Newman AB; Harris TB; Angleman S; Green C; Kritchevsky SB; Chertow GM; Cummings SR; Shlipak MG;
    Am Heart J; 2008 Jan; 155(1):62-8. PubMed ID: 18082491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study.
    Ix JH; Shlipak MG; Chertow GM; Whooley MA
    Circulation; 2007 Jan; 115(2):173-9. PubMed ID: 17190862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Increased Levels of Cystatin C and the Development of Cardiovascular Events or Mortality: A Systematic Review and Meta-Analysis.
    Einwoegerer CF; Domingueti CP
    Arq Bras Cardiol; 2018 Dec; 111(6):796-807. PubMed ID: 30281693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum cystatin C levels are associated with coronary artery disease and its severity.
    Wang GN; Sun K; Hu DL; Wu HH; Wang XZ; Zhang JS
    Clin Biochem; 2014 Nov; 47(16-17):176-81. PubMed ID: 25084128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystatin C and the risk for cardiovascular events in patients with asymptomatic carotid atherosclerosis.
    Hoke M; Amighi J; Mlekusch W; Schlager O; Exner M; Sabeti S; Dick P; Koppensteiner R; Minar E; Rumpold H; Wagner O; Schillinger M
    Stroke; 2010 Apr; 41(4):674-9. PubMed ID: 20150544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystatin C as a predictor of all-cause mortality and myocardial infarction in patients with non-ST-elevation acute coronary syndrome.
    Ristiniemi N; Lund J; Tertti R; Christensson A; Ilva T; Porela P; Pulkki K; Pettersson K
    Clin Biochem; 2012 May; 45(7-8):535-40. PubMed ID: 22394460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cystatin C: a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome.
    Jernberg T; Lindahl B; James S; Larsson A; Hansson LO; Wallentin L
    Circulation; 2004 Oct; 110(16):2342-8. PubMed ID: 15477399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.